Q9JHG7
Gene name |
Pik3cg (Pi3kg1) |
Protein name |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform |
Names |
PI3-kinase subunit gamma, PI3K-gamma, PI3Kgamma, PtdIns-3-kinase subunit gamma, Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma, PtdIns-3-kinase subunit p110-gamma, p110gamma, Phosphoinositide-3-kinase catalytic gamma polypeptide, Serine/threonine protein kinase PIK3CG, p120-PI3K |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:30955 |
EC number |
2.7.1.137: Phosphotransferases with an alcohol group as acceptor |
Protein Class |
|

Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
964-988 (Activation loop from InterPro)
Target domain |
797-1094 (Phosphatidylinositol 3-/4-kinase, catalytic domain) |
Relief mechanism |
|
Assay |
|
Autoinhibited structure

Activated structure

1 structures for Q9JHG7
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-Q9JHG7-F1 | Predicted | AlphaFoldDB |
46 variants for Q9JHG7
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs49039292 | 20 | R>C | No | EVA | |
rs3389244569 | 40 | I>T | No | EVA | |
rs3389235150 | 44 | L>V | No | EVA | |
rs3389210677 | 79 | L>P | No | EVA | |
rs3402475806 | 106 | W>R | No | EVA | |
rs3389229009 | 149 | A>T | No | EVA | |
rs3389233791 | 161 | D>E | No | EVA | |
rs3389245945 | 185 | M>V | No | EVA | |
rs29216533 | 262 | S>P | No | EVA | |
rs3389244530 | 267 | E>G | No | EVA | |
rs3389232672 | 309 | T>M | No | EVA | |
rs3403140122 | 310 | P>S | No | EVA | |
rs3389250140 | 343 | G>D | No | EVA | |
rs3389250094 | 361 | F>* | No | EVA | |
rs108525518 | 405 | A>T | No | EVA | |
rs3389222637 | 424 | P>S | No | EVA | |
rs3389168707 | 490 | K>E | No | EVA | |
rs3389250093 | 496 | S>I | No | EVA | |
rs108531174 | 561 | T>A | No | EVA | |
rs3389232670 | 593 | F>S | No | EVA | |
rs3389205655 | 594 | S>I | No | EVA | |
rs3389210606 | 603 | I>N | No | EVA | |
rs3389233840 | 616 | I>F | No | EVA | |
rs3389233813 | 616 | I>N | No | EVA | |
rs107601557 | 640 | V>A | No | EVA | |
rs3389235202 | 672 | Y>* | No | EVA | |
rs3389232673 | 683 | K>M | No | EVA | |
rs3389250157 | 690 | R>G | No | EVA | |
rs3402735203 | 693 | H>D | No | EVA | |
rs3403117030 | 697 | W>* | No | EVA | |
rs3389239541 | 706 | S>T | No | EVA | |
rs3389236463 | 710 | Q>* | No | EVA | |
rs3389250175 | 718 | E>D | No | EVA | |
rs3389234092 | 770 | K>R | No | EVA | |
rs3389237749 | 805 | A>V | No | EVA | |
rs3412564307 | 822 | V>L | No | EVA | |
rs3389210637 | 843 | L>M | No | EVA | |
rs3389233792 | 887 | T>R | No | EVA | |
rs3389222672 | 925 | V>E | No | EVA | |
rs3389210667 | 958 | G>* | No | EVA | |
rs3389237803 | 961 | F>L | No | EVA | |
rs3389231093 | 975 | F>E | No | EVA | |
rs108636709 | 987 | L>I | No | EVA | |
rs3389229028 | 1067 | Y>S | No | EVA | |
rs3389233854 | 1070 | D>Y | No | EVA | |
rs3403131315 | 1095 | K>RSAFLLV* | No | EVA |
No associated diseases with Q9JHG7
Functions
Description | ||
---|---|---|
EC Number | 2.7.1.137 | Phosphotransferases with an alcohol group as acceptor |
Subcellular Localization |
|
|
PANTHER Family | ||
PANTHER Subfamily | ||
PANTHER Protein Class | ||
PANTHER Pathway Category | No pathway information available |
7 GO annotations of cellular component
Name | Definition |
---|---|
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
membrane | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
phosphatidylinositol 3-kinase complex | A protein complex capable of phosphatidylinositol 3-kinase activity and containing subunits of any phosphatidylinositol 3-kinase (PI3K) enzyme. These complexes are divided in three classes (called I, II and III) that differ for their presence across taxonomic groups and for the type of their constituents. Catalytic subunits of phosphatidylinositol 3-kinase enzymes are present in all 3 classes; regulatory subunits of phosphatidylinositol 3-kinase enzymes are present in classes I and III; adaptor proteins have been observed in class II complexes and may be present in other classes too. |
phosphatidylinositol 3-kinase complex, class IA | A class I phosphatidylinositol 3-kinase complex that possesses 1-phosphatidylinositol-4-phosphate 3-kinase activity; comprises a catalytic class IA phosphoinositide 3-kinase (PI3K) subunit and an associated SH2 domain-containing regulatory subunit that is a member of a family of related proteins often called p85 proteins. Through the interaction with the SH2-containing adaptor subunits, Class IA PI3K catalytic subunits are linked to tyrosine kinase signaling pathways. |
phosphatidylinositol 3-kinase complex, class IB | A class I phosphatidylinositol 3-kinase complex that possesses 1-phosphatidylinositol-4-phosphate 3-kinase activity; comprises a catalytic class IB phosphoinositide 3-kinase (PI3K) subunit and an associated regulatory subunit that is larger than, and unrelated to, the p85 proteins present in class IA complexes. Class IB PI3Ks are stimulated by G-proteins and do not interact with the SH2-domain containing adaptors that bind to Class IA PI3Ks. |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
11 GO annotations of molecular function
Name | Definition |
---|---|
1-phosphatidylinositol-3-kinase activity | Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol + ATP = a 1-phosphatidyl-1D-myo-inositol 3-phosphate + ADP + 2 H(+). |
1-phosphatidylinositol-4-phosphate 3-kinase activity | Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4-phosphate + ATP = 1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + ADP + 2 H(+). |
ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
ephrin receptor binding | Binding to an ephrin receptor. |
identical protein binding | Binding to an identical protein or proteins. |
kinase activity | Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule. |
phosphatidylinositol kinase activity | Catalysis of the reaction: ATP + a phosphatidylinositol = ADP + a phosphatidylinositol phosphate. |
phosphatidylinositol-3,4-bisphosphate 5-kinase activity | Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + ATP = a 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + ADP + 2 H(+). |
phosphatidylinositol-4,5-bisphosphate 3-kinase activity | Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + ATP = a 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + ADP + 2 H(+). |
protein serine kinase activity | Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate. |
protein serine/threonine kinase activity | Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate. |
28 GO annotations of biological process
Name | Definition |
---|---|
angiogenesis | Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. |
cell migration | The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms. |
cellular response to cAMP | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus. |
chemotaxis | The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). |
endocytosis | A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a small region of the plasma membrane to form a new membrane-bounded vesicle. |
G protein-coupled receptor signaling pathway | The series of molecular signals initiated by a ligand binding to its receptor, in which the activated receptor promotes the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, and ends with regulation of a downstream cellular process. The pathway can start from the plasma membrane, Golgi or nuclear membrane. |
hepatocyte apoptotic process | Any apoptotic process in a hepatocyte, the main structural component of the liver. |
immune system process | Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats. |
inflammatory response | The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
negative regulation of fibroblast apoptotic process | Any process that stops, prevents or reduces the frequency, rate or extent of fibroblast apoptotic process. |
negative regulation of triglyceride catabolic process | Any process that decreases the frequency, rate, or extent of the chemical reactions and pathways resulting in the breakdown of triglyceride. |
phosphatidylinositol 3-kinase signaling | A series of reactions within the signal-receiving cell, mediated by the intracellular phosphatidylinositol 3-kinase (PI3K). Many cell surface receptor linked signaling pathways signal through PI3K to regulate numerous cellular functions. |
phosphatidylinositol phosphate biosynthetic process | The chemical reactions and pathways resulting in the formation of phosphatidylinositol phosphate. |
phosphatidylinositol-3-phosphate biosynthetic process | The chemical reactions and pathways resulting in the formation of phosphatidylinositol-3-phosphate, a phosphatidylinositol monophosphate carrying the phosphate group at the 3-position. |
phosphatidylinositol-mediated signaling | The series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives. |
phosphorylation | The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide. |
positive regulation of acute inflammatory response | Any process that activates or increases the frequency, rate, or extent of an acute inflammatory response. |
positive regulation of catalytic activity | Any process that activates or increases the activity of an enzyme. |
positive regulation of cytosolic calcium ion concentration | Any process that increases the concentration of calcium ions in the cytosol. |
positive regulation of endothelial cell migration | Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium. |
positive regulation of MAP kinase activity | Any process that activates or increases the frequency, rate or extent of MAP kinase activity. |
positive regulation of protein kinase B signaling | Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B. |
positive regulation of Rac protein signal transduction | Any process that activates or increases the frequency, rate or extent of Rac protein signal transduction. |
protein phosphorylation | The process of introducing a phosphate group on to a protein. |
regulation of calcium ion transmembrane transport | Any process that modulates the frequency, rate or extent of calcium ion transmembrane transport. |
regulation of protein phosphorylation | Any process that modulates the frequency, rate or extent of addition of phosphate groups into an amino acid in a protein. |
secretory granule localization | Any process in which a secretory granule is transported to, and/or maintained in, a specific location within the cell. |
sphingosine-1-phosphate receptor signaling pathway | A G protein-coupled receptor signaling pathway initiated by sphingosine-1-phosphate binding to its receptor on the surface of a cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
13 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
P32871 | PIK3CA | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Bos taurus (Bovine) | PR |
P42336 | PIK3CA | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Homo sapiens (Human) | PR |
P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Homo sapiens (Human) | PR |
O00329 | PIK3CD | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Homo sapiens (Human) | PR |
P48736 | PIK3CG | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Homo sapiens (Human) | PR |
P42337 | Pik3ca | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Mus musculus (Mouse) | PR |
Q8BTI9 | Pik3cb | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Mus musculus (Mouse) | PR |
Q8BKC8 | Pi4kb | Phosphatidylinositol 4-kinase beta | Mus musculus (Mouse) | PR |
Q61194 | Pik3c2a | Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha | Mus musculus (Mouse) | PR |
O35904 | Pik3cd | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Mus musculus (Mouse) | PR |
O02697 | PIK3CG | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Sus scrofa (Pig) | PR |
Q9Z1L0 | Pik3cb | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Rattus norvegicus (Rat) | PR |
Q94125 | age-1 | Phosphatidylinositol 3-kinase age-1 | Caenorhabditis elegans | PR |
10 | 20 | 30 | 40 | 50 | 60 |
MELENYEQPV | VLREDNLRRR | RRMKPRSAAG | SLSSMELIPI | EFVLPTSQRI | SKTPETALLH |
70 | 80 | 90 | 100 | 110 | 120 |
VAGHGNVEQM | KAQVWLRALE | TSVAAEFYHR | LGPDQFLLLY | QKKGQWYEIY | DRYQVVQTLD |
130 | 140 | 150 | 160 | 170 | 180 |
CLHYWKLMHK | SPGQIHVVQR | HVPSEETLAF | QKQLTSLIGY | DVTDISNVHD | DELEFTRRRL |
190 | 200 | 210 | 220 | 230 | 240 |
VTPRMAEVAG | RDAKLYAMHP | WVTSKPLPDY | LSKKIANNCI | FIVIHRGTTS | QTIKVSADDT |
250 | 260 | 270 | 280 | 290 | 300 |
PGTILQSFFT | KMAKKKSLMN | ISESQSEQDF | VLRVCGRDEY | LVGETPLKNF | QWVRQCLKNG |
310 | 320 | 330 | 340 | 350 | 360 |
DEIHLVLDTP | PDPALDEVRK | EEWPLVDDCT | GVTGYHEQLT | IHGKDHESVF | TVSLWDCDRK |
370 | 380 | 390 | 400 | 410 | 420 |
FRVKIRGIDI | PVLPRNTDLT | VFVEANIQHG | QQVLCQRRTS | PKPFAEEVLW | NVWLEFGIKI |
430 | 440 | 450 | 460 | 470 | 480 |
KDLPKGALLN | LQIYCCKTPS | LSSKASAETP | GSESKGKAQL | LYYVNLLLID | HRFLLRHGDY |
490 | 500 | 510 | 520 | 530 | 540 |
VLHMWQISGK | AEEQGSFNAD | KLTSATNPDK | ENSMSISILL | DNYCHPIALP | KHRPTPDPEG |
550 | 560 | 570 | 580 | 590 | 600 |
DRVRAEMPNQ | LRKQLEAIIA | TDPLNPLTAE | DKELLWHFRY | ESLKHPKAYP | KLFSSVKWGQ |
610 | 620 | 630 | 640 | 650 | 660 |
QEIVAKTYQL | LARREIWDQS | ALDVGLTMQL | LDCNFSDENV | RAIAVQKLES | LEDDDVLHYL |
670 | 680 | 690 | 700 | 710 | 720 |
LQLVQAVKFE | PYHDSALARF | LLKRGLRNKR | IGHFLFWFLR | SEIAQSRHYQ | QRFAVILEAY |
730 | 740 | 750 | 760 | 770 | 780 |
LRGCGTAMLQ | DFTQQVHVIE | MLQKVTIDIK | SLSAEKYDVS | SQVISQLKQK | LESLQNSNLP |
790 | 800 | 810 | 820 | 830 | 840 |
ESFRVPYDPG | LKAGTLVIEK | CKVMASKKKP | LWLEFKCADP | TVLSNETIGI | IFKHGDDLRQ |
850 | 860 | 870 | 880 | 890 | 900 |
DMLILQILRI | MESIWETESL | DLCLLPYGCI | STGDKIGMIE | IVKDATTIAQ | IQQSTVGNTG |
910 | 920 | 930 | 940 | 950 | 960 |
AFKDEVLNHW | LKEKCPIEEK | FQAAVERFVY | SCAGYCVATF | VLGIGDRHND | NIMISETGNL |
970 | 980 | 990 | 1000 | 1010 | 1020 |
FHIDFGHILG | NYKSFLGINK | ERVPFVLTPD | FLFVMGSSGK | KTSPHFQKFQ | DVCVRAYLAL |
1030 | 1040 | 1050 | 1060 | 1070 | 1080 |
RHHTNLLIIL | FSMMLMTGMP | QLTSKEDIEY | IRDALTVGKS | EEDAKKYFLD | QIEVCRDKGW |
1090 | 1100 | ||||
TVQFNWFLHL | VLGIKQGEKH | SA |